findmyKOL
Clinical trialNCT02170441CompletedObservational

Global Consortium for Drug-resistant Tuberculosis Diagnostics

SponsorUniversity of California, San DiegoEnrollment1,128TuberculosisTuberculosis, Multidrug-Resistant
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this study is to evaluate time to diagnosis for three assays (line probe, pyrosequencing, and Microscopic Observation Drug Susceptibility Assay \[MODS\]) to detect resistance to first and second-line anti-tuberculosis (TB) drugs in Mycobacterium tuberculosis (Mtb) strains in 7 days or less, allowing for rapid diagnosis of extensively drug-resistant TB (XDR-TB).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

India
  • P.D. Hinduja National Hospital and Medical Research Centre

    Mumbai, India

Moldova
  • Phthisiopneumology Institute

    Chisinau, Moldova

South Africa
  • Department of Biomedical Sciences, Stellenbosch University

    Cape Town, South Africa

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2012
Primary completion
30 Jun 2014
Completion
30 Jun 2014
Last update posted
23 Jun 2014
Registered enrollment
1,128
Registry id
NCT02170441

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.